Doctors are not safe with some patients.

Published Date: 16 Feb 2023

Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.

Read Full News

Latest News

Bladder Issues Linger in Kids Treated for Ureter Swelling

Many children surgically treated for a swelling at the end of the ureter have lasting bladder symptoms, such as holding urine or trouble passing stools.

Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice

Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice

Practical Implications of Targeted Therapies in mHSPC Care

Practical Implications of Targeted Therapies in mHSPC Care

Clinical Data and Expert Perspectives on Emerging Bispecific ADCs in Urothelial Carcinoma

Clinical Data and Expert Perspectives on Emerging Bispecific ADCs in Urothelial Carcinoma

Mastering Evolving Evidence on Systemic Immunotherapy in the Management of BCG-Naïve, High-Risk NMIBC

Mastering Evolving Evidence on Systemic Immunotherapy in the Management of BCG-Naïve, High-Risk NMIBC

Beyond BCG Alone: Clinical Pearls for Integrating Immunotherapy Earlier in High-Risk NMIBC

Beyond BCG Alone: Clinical Pearls for Integrating Immunotherapy Earlier in High-Risk NMIBC

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Latest News

Many children surgically treated for a swelling at the end of the ureter have lasting bladder symptoms, such as holding urine or trouble passing stools.

Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice

Practical Implications of Targeted Therapies in mHSPC Care

Clinical Data and Expert Perspectives on Emerging Bispecific ADCs in Urothelial Carcinoma

Mastering Evolving Evidence on Systemic Immunotherapy in the Management of BCG-Naïve, High-Risk NMIBC

Beyond BCG Alone: Clinical Pearls for Integrating Immunotherapy Earlier in High-Risk NMIBC

News All Time

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Shaping the Future of Muscle-Invasive Bladder Cancer Treatment With the Integration of Immunotherapy and Multidisciplinary Care

Shaping the Future of Muscle-Invasive Bladder Cancer Treatment With the Integration of Immunotherapy and Multidisciplinary Care

Advancing mHSPC Management: From Clinical Guidelines to Emerging Biomarker-Directed Therapies

Advancing mHSPC Management: From Clinical Guidelines to Emerging Biomarker-Directed Therapies

Optimizing mHSPC Care: Integrating Novel Combination Therapies and the Strategies for Multidisciplinary Management

Optimizing mHSPC Care: Integrating Novel Combination Therapies and the Strategies for Multidisciplinary Management

Personalized Decision-Making for Patients With Advanced HSPC

Personalized Decision-Making for Patients With Advanced HSPC

Half of Patients With Post-BCG Bladder Cancer Achieve CR With Nonviral Gene Therapy

Detalimogene voraplasmid lead to numerous durable complete responses with favorable safety

Too Much or Too Little Opioid Pain Relief May Drive Refills After Urologic Surgery

Discharge prescription mismatch versus inpatient dose significantly increased refill rate

Durvalumab Plus BCG Cut Early Recurrence of High-Risk Bladder Cancer

POTOMAC data support a year's worth of immuontherapy paired with BCG induction and maintenance

Major Complete Response Rate in Very High-Risk Bladder Cancer With Combo Treatment

Only three of 37 patients did not achieve CR at 6 months with pembrolizumab and BCG
HTTP error: 503HTTP error: 503

Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer

U.S. study supports findings from a global trial using an external control arm

He Inserted a Cable in His Penis. 10 Years Later, He Needed Surgery.

Patient in his 60s eventually developed sepsis

Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse

Significantly higher risk of sedative, opioid, cocaine abuse compared with no ED diagnosis

GLP-1 Drugs Linked to Significant Boost in Testosterone Levels for Men

Weight loss likely not the only reason for improvement, researcher says

Tibial Nerve Stimulation for Overactive Bladder Tied to Better Quality of Life

But main results from sham-controlled trial still outstanding

Recommended News For You

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

In inflammatory breast cancer, ER beta regulates estrogen signaling.

Guidelines for cervical cancer screening and the risk of preterm birth in young women.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

US Cancer Trials Heavily Favor Single Drugs Over Care Issues

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

Recommended Articles For You

Understanding Dasatinib: A Promising Drug for Cancer Treatment  

Pediatric Advances in Long-Term Survivorship Science for Childhood Cancer 

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025 

Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

4.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

5.

Pressing the Sleep button could have a positive impact on cognition.

1.

Rehabilitation of Hand Dexterity Following Hematologic Treatment-Associated Deconditioning

2.

The benefits of using magnesium sulfate during pregnancy 

3.

Understanding the Importance of Knowing Your MCV Normal Range

4.

Proteogenomic Classification of Myeloid Disorders: Integrating Molecular Profiles for Precision Medicine

5.

Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part XVI

2.

Evidence-Based Oncology

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

4.

When Unexplained Bruising May Require Blood Testing

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot